Sathyanarayanan Sriram 4
4 · Codiak BioSciences, Inc. · Filed Sep 28, 2021
Insider Transaction Report
Form 4
Sathyanarayanan Sriram
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2021-08-06$3.29/sh+1,300$4,277→ 1,300 total - Exercise/Conversion
Common Stock
2021-08-09$3.29/sh+1,300$4,277→ 1,300 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-08-06+1,300→ 49,966 totalExercise: $3.29Exp: 2027-07-24→ Common Stock (1,300 underlying) - Sale
Common Stock
2021-08-06$20.16/sh−1,300$26,206→ 0 total - Sale
Common Stock
2021-08-09$21.31/sh−751$16,003→ 549 total - Sale
Common Stock
2021-08-09$21.79/sh−549$11,962→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-08-09+1,300→ 48,666 totalExercise: $3.29Exp: 2027-07-24→ Common Stock (1,300 underlying)
Footnotes (6)
- [F1]The transactions reported in this Form 4 were inadvertently reported late due to an administrative oversight related to communications of the transactions.
- [F2]The sales reported in this Form 4 were effected pursuant to a previously adopted Rule 10b5-1 trading plan.
- [F3]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $20.03 to $20.26 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F4]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $20.72 to $21.71 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F5]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $21.72 to $21.91 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F6]The shares underlying this option are fully vested.